InMed Pharmaceuticals Inc. — Director's Dealing 2021

Dec 31, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: InMed Pharmaceuticals Inc. (INM)
CIK: 0001728328
Period of Report: 2021-12-29

Reporting Person: Cutler Adam D. (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-12-29	Employee Stock Option (Right to Buy)	$1.32	A	7000	Acquired	2026-12-28	Common shares (7000)	Direct

Footnotes

F1: The options were granted on 12/29/2021 and will vest 100% on the one year anniversary of the grant date (Dec 29, 2022) or immediately prior to the next AGM, whichever is sooner.